2026 年面向专业投资者公开发行短期公司债券（第一期） 证券代码：524639 证券简称：26 广发 D1 广发证券股份有限公司 发行结果公告 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记 载、误导性陈述或者重大遗漏。 广发证券股份有限公司（以下简称"发行人"）公开发行面值余额不超过人 民币 300 亿元短期公司债券已获得中国证券监督管理委员会证监许可〔2025〕818 号文注册。根据《广发证券股份有限公司 2026 年面向专业投资者公开发行短期 公司债券（第一期）发行公告》，广发证券股份有限公司 2026 年面向专业投资者 公开发行短期公司债券（第一期）（以下简称"本期债券"）计划发行规模不超过 30 亿元（含），发行价格为每张 100 元，采取网下面向专业机构投资者询价配售 的方式发行。 本期债券发行时间自 2026 年 1 月 22 日至 2026 年 1 月 23 日，最终发行规模 为 30 亿元，最终票面利率为 1.68%，认购倍数为 4.40 倍。 华泰联合证券有限责任公司（公章） 年 月 日 特此公告。 1 （本页无正文，为《广发证券股份有限公司 2026 年面向专业投资者 ...

Group 1: Partnership and Financial Aspects - The collaboration between Zhongsheng Ruichuang and Qilu Pharmaceutical involves a licensing agreement for the RAY1225 injection, allowing Qilu to produce and commercialize the product in China, while Zhongsheng retains all intellectual property rights [1][3]. - Zhongsheng will receive an upfront payment of RMB 200 million and may earn up to RMB 800 million in milestone payments based on development and sales achievements [3]. - After the first commercial sale of the licensed product, Zhongsheng is entitled to a double-digit percentage of net sales in the licensed regions [3]. Group 2: Innovation and Drug Development - Zhongsheng focuses on innovative drug development, particularly in metabolic diseases and respiratory diseases, with two projects already approved for market and several others in clinical trials [6][8]. - The RAY1225 injection is a novel dual-agonist peptide drug with potential for bi-weekly administration, targeting type 2 diabetes and obesity, currently undergoing multiple Phase III clinical trials [10][11]. - The company is also developing ZSP1601, a treatment for metabolic dysfunction-related fatty liver disease (MASH), which has shown promising results in early clinical trials [6][12]. Group 3: Market Strategy and Future Outlook - The partnership aims to leverage both companies' strengths to enhance commercialization efficiency and market reach, while reducing operational costs related to production and marketing [3]. - Zhongsheng remains committed to exploring overseas markets and does not intend to limit its international expansion despite the current focus on the Chinese market [4]. - The company is actively pursuing innovative solutions to meet unmet clinical needs, particularly in the treatment of MASH, which currently lacks approved therapies in China [12].

根据深圳证券交易所债券上市的有关规定，广发证券股份有限公司 2026 年 面向专业投资者公开发行次级债券（第一期）符合深圳证券交易所债券上市条件， 将于 2026 年 1 月 26 日起在深圳证券交易所上市，并面向专业机构投资者交易， 交易方式包括匹配成交、点击成交、询价成交、竞买成交和协商成交。债券相关 要素如下： | 债券名称 | | 广发证券股份有限公司 | 年面向专业投资者公开发 | | | 2026 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 行次级债券（第一期） | | | | | | | | | | 债券简称 | 26 广发 C1 | | | | | | | | | | | 债券代码 | 524627 | | | | | | | | | | | 信用评级 | 主体评级 | | | | | | | AAA | | AAA/债项评级 | | 评级机构 | | | | | | | | | | 中诚信国际信用评级有限责任公司 | | 发行总额（亿元） | 17.2 | | | | ...

Market Overview - The securities sector experienced a slight decline of 0.07% on January 23, with GF Securities leading the drop [1] - The Shanghai Composite Index closed at 4136.16, up 0.33%, while the Shenzhen Component Index closed at 14439.66, up 0.79% [1] Individual Stock Performance - Notable gainers included: - Huayin Securities (002945) with a closing price of 17.86, up 3.78% and a trading volume of 476,000 shares, totaling 846 million yuan [1] - Xiangcai Shares (600095) closed at 11.70, up 2.18% with a trading volume of 597,900 shares, totaling 701 million yuan [1] - Major decliners included: - GF Securities (000776) closed at 22.31, down 1.24% with a trading volume of 580,600 shares, totaling 1.3 billion yuan [2] - Tushin Securities (002736) closed at 12.56, down 1.02% with a trading volume of 586,200 shares, totaling 740 million yuan [2] Fund Flow Analysis - The securities sector saw a net outflow of 1.644 billion yuan from institutional investors, while retail investors contributed a net inflow of 1.15 billion yuan [2][3] - Key stocks with significant fund flows included: - Guotai Junan (601211) with a net inflow of 180 million yuan from institutional investors [3] - Huayin Securities (002945) had a net inflow of 86.16 million yuan from institutional investors [3] ETF Performance - Financial Technology ETF (516100) saw a decline of 5.40% over the past five days, with a current PE ratio of 76.53 and a net subscription of 21.78 million yuan [5] - Securities ETF (515010) decreased by 1.29% over the past five days, with a PE ratio of 17.02 and a net redemption of 76.32 million yuan [5]

Investment Rating - The report maintains a positive recommendation for the industry, indicating an upward trend in fundamentals despite short-term fluctuations in performance [4]. Core Insights - The non-bank sector's public active equity allocation ratio has increased quarter-on-quarter, with a reduction in underweight levels [2]. - The insurance sector has seen a significant increase in active equity holdings, with a quarter-on-quarter growth of 117% in A-share active equity public fund heavy positions [3]. - The brokerage sector's active equity holdings have also risen, with a quarter-on-quarter increase of 14% in A-share active equity public fund heavy positions [5]. - Multi-financial companies, particularly Jiufang Zhituo Holdings, have shown a notable increase in allocation ratios [6]. Summary by Sections Non-Bank Sector - The total heavy stock allocation in the non-bank financial sector reached 40.9 billion yuan, with a configuration ratio of 2.51%, up by 1.03 percentage points quarter-on-quarter, and an underweight ratio of 3.87%, narrowing by 0.92 percentage points [2]. Insurance Sector - The A-share active equity public fund heavy positions in the insurance sector reached 28 billion yuan, with a configuration ratio of 1.72%, up by 0.95 percentage points quarter-on-quarter. The underweight ratio is 0.74 percentage points, down by 0.63 percentage points [3]. - Key individual stock allocations include China Life at 0.08%, Ping An at 1.11%, and others, with varying degrees of over- and under-allocation [3]. Brokerage Sector - The A-share active equity public fund heavy positions in the brokerage sector reached 11.8 billion yuan, with a configuration ratio of 0.73%, up by 0.10 percentage points quarter-on-quarter, and an underweight ratio of 2.67 percentage points, narrowing by 0.29 percentage points [5]. - Major holdings include Huatai Securities and CITIC Securities, with slight increases in their respective ratios [5]. Multi-Financial Sector - Jiufang Zhituo Holdings has seen a significant increase in its allocation ratio, while other multi-financial companies are also recommended for their strong performance potential [6].

Core Viewpoint - Ningbo Jiayin Electromechanical Technology Co., Ltd. has signed a counseling agreement with GF Securities to apply for public stock issuance and listing on the Beijing Stock Exchange, marking a significant step in its growth strategy [1] Group 1: Company Overview - Jiayin Technology was established in 2001 and is recognized as a national high-tech enterprise specializing in the research and production of core execution, control components, and sensors for smart home appliances [1] - The company operates 16 business divisions, providing a comprehensive one-stop solution for most key components required in smart home appliances [1] - Jiayin Technology's products, including solenoid valves, electromagnetic pumps, and flow meters, have established a unique market advantage and are widely used by hundreds of well-known domestic and international brands such as Philips, Panasonic, Siemens, Midea, SEB, and Xiaomi [1] Group 2: Financial Data - For the years 2023 and 2024, Jiayin Technology reported audited net profits attributable to shareholders of the listed company of 44.6687 million yuan and 56.5135 million yuan, respectively [2] - The weighted average return on net assets for the same years was 19.29% and 19.91%, meeting the financial conditions required for listing on the Beijing Stock Exchange as per the listing rules [2]

针对这一背离现象，业内分析认为主要原因有三点。首先，券商行情往往具有"提前量"特征。早在2024年第四季度A股启动 上涨行情时，券商板块已抢先大涨，提前透支了2025年的业绩增长利好。当正式财报落地时，市场资金倾向于获利了结， 进入"卖事实"阶段，导致业绩增长难以推动股价进一步上行。 其次，资金虹吸效应显著。2025年市场呈现极致的结构分化，人工智能、半导体、算力等科技赛道因具备高成长性和广阔 的想象空间，持续吸引增量资金。相比之下，券商股被市场视为传统周期品种，缺乏短期的爆发性叙事，导致资金吸引力 下降，"牛市旗手"的光环有所褪色。 【环球网财经综合报道】尽管上市券商2025年业绩预喜，净利润大幅增长，但其股价表现却未能同步跟进，呈现出明显 的"滞涨"态势。近期披露的业绩预告显示，多家券商营收与净利双增，但在二级市场上，券商板块去年整体跑输大盘，这 种"业绩热、股价冷"的反差引发了市场的广泛关注。 回顾2025年全年，A股市场震荡走高，结构性行情突出。科技赛道表现抢眼，主要指数涨幅显著，而券商板块表现相对低 迷，未能跑赢沪深300等大盘指数。然而，从基本面来看，券商行业却展现出强劲的增长韧性。数据显示，上市 ...

新华财经北京1月23日电沪深两市三大股指23日早间普遍小幅高开。各股指盘初在未回补与上一交易日 之间缺口的情况下震荡上扬，10时16分后开始逐渐收窄涨幅，其中，沪指和深成指在完成缺口回补后再 度上扬。北证50指数23日早间表现强势，显著高开，至午间收盘时大幅上涨。 从盘面来看，光伏、贵金属、医药商业板块在盘初涨幅靠前，燃气、航天航空、煤炭板块在盘初跌幅靠 前。海南自贸、仿制药、锂矿、电网设备、卫星互联网、6G概念、培育钻石等多个板块在盘中相继走 强。至午间收盘时，光伏设备板块掀涨停潮，因板块内成分股多有交叉，HIT电池、TOPCon电池、钙 钛矿电池等光伏领域相关板块均有大幅上涨。卫星互联网、6G概念、贵金属、珠宝首饰、有色金属、 锂矿、医药商业等多板块亦有较大幅度上涨。保险、高带宽内存、燃气等板块跌幅靠前，但整体跌幅不 大。 至午间收盘时，上证指数报4133.58点，涨幅0.27%，成交额约8073亿元；深证成指报14360.96点，涨幅 0.24%，成交额约10856亿元；创业板指报3322.96点，跌幅0.17%，成交额约5063亿元；科创综指报 1879.53点，涨幅0.76%，成交额约2084亿元； ...

Group 1 - The photovoltaic sector experienced a significant surge, with the photovoltaic ETF Huaxia (515370) rising by 5.17%, and stocks such as Dongfang Risheng, Maiwei Co., Laplace, and Aotwei hitting the 20% limit up, while Jiejia Weichuang increased by over 18% [1] - China has submitted applications for over 200,000 satellite constellations, marking a new phase of large-scale deployment in commercial space, which will directly drive long-term demand for space photovoltaics [1] - According to Guangfa Securities, space photovoltaics are expected to benefit from the global commercial space boom, with existing low-orbit satellite plans potentially generating nearly 10GW of demand for space photovoltaics in the future [1] Group 2 - The Huaxia photovoltaic ETF (515370) and its connected funds (012885/012886) track the CSI Photovoltaic Industry Index, which includes upstream, midstream, and downstream companies in the photovoltaic industry, such as silicon wafers, polysilicon, battery cells, cables, photovoltaic glass, battery modules, inverters, photovoltaic brackets, and power stations, reflecting the overall performance of the photovoltaic industry [1] - The index has a photovoltaic content of 83.64%, ranking first in the entire market dimension [1]

Group 1 - The photovoltaic sector experienced a significant surge, with the China Securities Photovoltaic Industry Index rising by 5.27% as of January 23, 2026, driven by strong performances from stocks such as Laplace (+20.01%), Maiwei (+20.00%), and Dongfang Risheng (+20.00) [1] - Elon Musk, CEO of Tesla, expressed strong support for space photovoltaic technology during a discussion at the World Economic Forum, revealing plans for SpaceX and Tesla to enhance solar manufacturing capacity to 100GW annually over the next three years [1] - China has submitted applications for 203,000 satellite orbits to the ITU, which is expected to generate nearly 10GW of demand for space photovoltaic technology [1] - Heterojunction (HJT) solar cells are gaining traction due to their simple processes and high yields, opening up new opportunities in emerging applications such as computational satellites [1] - Space photovoltaic energy, which harnesses solar energy in outer space for power supply, is becoming a strategic solution for commercial aerospace and high-end applications, marking a pivotal moment for the sector [1] Group 2 - As of December 31, 2025, the top ten weighted stocks in the China Securities Photovoltaic Industry Index include TBEA, LONGi Green Energy, Sungrow Power, TCL Technology, Tongwei Co., Maiwei, Deye, Chint Electric, TCL Zhonghuan, and JinkoSolar, collectively accounting for 55.11% of the index [2] - The Jiahua Photovoltaic ETF (159123) tracks the China Securities Photovoltaic Industry Index, providing a convenient tool for investing across the entire photovoltaic industry chain [3] - Investors can also access photovoltaic industry investment opportunities through the Jiahua Photovoltaic ETF's off-market connection (014605) [4]